
Portfolio management at GlaxoSmithKline
An often-quoted paper by Sharpe and Keelin, back in 1998, reported how managers at GlaxoSmithKline redesigned their portfolio selection process.
An often-quoted paper by Sharpe and Keelin, back in 1998, reported how managers at GlaxoSmithKline redesigned their portfolio selection process.
A good understanding of the R&D pipeline and portfolio is essential to reduce waste, duplication and poor use of valuable resources, says Joe de Sousa
Many of the tools used in valuing and selecting projects are only really applicable to large portfolios because they assess value by using statistical concepts
Have your say / Follow us
R&D Today is the outreach site for the Research and Development Management Association, a charitable organisation that supports research, best practice and innovation. www.radma.net
© Copyright R&D Today
All rights reserved.